250 related articles for article (PubMed ID: 16615820)
1. Viral load, CD4+ T-lymphocyte counts and antibody titres in HIV-1 infected untreated children in Kenya; implication for immunodeficiency and AIDS progression.
Ochieng W; Ogoyi D; Mulaa FJ; Ogola S; Musoke R; Otsyula MG
Afr Health Sci; 2006 Mar; 6(1):3-13. PubMed ID: 16615820
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
4. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
[TBL] [Abstract][Full Text] [Related]
5. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
6. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
[TBL] [Abstract][Full Text] [Related]
8. Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.
Paintsil E; Ghebremichael M; Romano S; Andiman WA
Pediatr Infect Dis J; 2008 Jul; 27(7):629-35. PubMed ID: 18520446
[TBL] [Abstract][Full Text] [Related]
9. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
10. Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 10(6)/l.
García F; Vidal C; Gatell JM; Miró JM; Soriano A; Pumarola T
AIDS; 1997 Jan; 11(1):53-7. PubMed ID: 9110075
[TBL] [Abstract][Full Text] [Related]
11. Differences in HIV-1 viral loads between male and female antiretroviral-untreated Mexican patients.
Ballesteros-Zebadúa P; Villarreal C; Cocho G; Huerta L; Estrada JL
Arch Med Res; 2013 May; 44(4):296-301. PubMed ID: 23608673
[TBL] [Abstract][Full Text] [Related]
12. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
13. IL-8 Alterations in HIV-1 Infected Children With Disease Progression.
Pananghat AN; Aggarwal H; Prakash SS; Makhdoomi MA; Singh R; Lodha R; Ali S; Srinivas M; Das BK; Pandey RM; Kabra SK; Luthra K
Medicine (Baltimore); 2016 May; 95(21):e3734. PubMed ID: 27227934
[TBL] [Abstract][Full Text] [Related]
14. Correlation of baseline quantitative plasma human immunodeficiency (HIV) type 1 RNA viral load with clinical status and CD4+ T-cell counts in treatment-naïve HIV-positive patients in Singapore.
Ho BC; Laudette-Aboulhab J; Se-Thoe SY; Chan SP; Ling AE; Leo YS
Ann Acad Med Singap; 2000 Nov; 29(6):708-13. PubMed ID: 11269974
[TBL] [Abstract][Full Text] [Related]
15. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
16. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
17. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status.
van Rossum AM; Scherpbier HJ; van Lochem EG; Pakker NG; Slieker WA; Wolthers KC; Roos MT; Kuijpers JH; Hooijkaas H; Hartwig NG; Geelen SP; Wolfs TF; Lange JM; Miedema F; de Groot R;
AIDS; 2001 Nov; 15(17):2267-75. PubMed ID: 11698700
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type-1 (HIV-1) disease progression and viral activity: a seroepidemiological and molecular study.
Bukhari SZ; Qazi JI; Ashshi AM; Zia N
J Coll Physicians Surg Pak; 2012 Sep; 22(9):565-9. PubMed ID: 22980609
[TBL] [Abstract][Full Text] [Related]
20. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
